CoRiCal is a tool to help people make decisions about getting a COVID-19 vaccine. It shows how the vaccine can lower the chance of catching, getting sick from or dying from COVID-19. It also shows the chance of getting rare side effects from the vaccines.
The tool shows the chance based on your age, sex, and vaccinations. You can choose to see the results ‘as a chance' or 'per million people' by clicking on the tabs.
The results shown are only a guide. The tool shows the average result for people with the same sex and age as you. This tool does not consider other things that can change your chance of infection or illness from COVID-19. This includes your general health, where you work or go to school, or your COVID-19 safe behaviours.
When making decisions about getting a COVID-19 vaccine, you should also consider how your chance might change in the future. This might include a change in the number of cases in your community or travel to an area with more cases.
Watch these videos for examples of how to understand the risk calculator results: general model, kids model, long covid model.
How are the COVID-19 risks calculated?
We have used trusted data sources (such as government reports and published scientific studies) to create a Bayesian Network model. A Bayesian network is a mathematical model that shows the relationship between factors and how they influence the chance of something happening. Examples of the CoRiCal model are here for Astrazeneca vaccine, here for the Pfizer vaccine, and here for long COVID. The data sources used and assumptions are listed here for Astrazeneca vaccine, here for the Pfizer vaccine, and here for the Paediatric Pfizer vaccine.
Why don’t all the CoRiCal models include health conditions that affect COVID-19 outcomes? (e.g. obesity, diabetes, cardiovascular disease, immunosuppression etc.)
Currently, only the long COVID risk calculator can take these factors into account. This is because of limited data for the other calculators. However, we are working on a new model for the Pfizer COVID-19 vaccine that will take health conditions into account.
Which COVID-19 variant is the calculator based on?
The current calculator assumes that 100% of COVID-19 cases are caused by the Omicron variant. We may update this in future.
How does having had COVID-19 previously and vaccination affect the outcomes?
The long COVID risk calculator includes how many times you’ve had COVID-19. COVID-19 can induce an immune response.
This may give some short-term protection from getting COVID-19 again. But it may also increase your chance of getting long COVID.
For the Pfizer COVID-19 vaccine, we are collecting new data on this and will update CoRiCal once we have enough evidence.
Are the rates given per whole population, or for the relevant age group population?
The rates are displayed as the number per 1 million people in the selected age and sex group.
You can also display the results as a “1 in x” chance for the selected age and sex group.
Why is the risk of dying different between the risk charts and the interactive calculator?
This is because the interactive calculator is the latest update and assumes 100% of cases are caused by the Omicron variant.
The risk charts were designed in January 2022, when it was assumed that 10% of cases were Delta and 90% were Omicron.
Is the calculator based on Australian data?
We have used Australian data sources where possible. Where Australian data are not available, we have used overseas data. All data sources are shown here (see Pfizer data sources , AstraZeneca data sources , and long COVID data sources).
What are the assumptions in the CoRiCal model?
Unfortunately there is not always data available to fit every situation. For example, if data are not available for specific age groups, we have to assume the chance is the same for a wide age group (e.g. 18-60 years). For a full explanation of the assumptions for each calculator, please follow the links in the MORE INFO tab.
What are the most common side-effects of the COVID-19 vaccines?
Pain around the injection site is the most frequently reported local side effect, most often the day after injection. According to a study of more than 600,000 people in the UK, local side effects were reported by:
No. The CoRiCal calculator is designed as a shared decision-making tool to help people weigh up the pros and cons of COVID-19 vaccines. It has been developed to simplify complex information about rare outcomes from COVID-19 and vaccines.
The calculator has been developed by researchers and clinicians who are not employed by the Immunisation Coalition, or vaccine manufacturers. The authors have not received any specific instructions from these organisations about the content.
The risk estimates that have been used are transparent and listed on the website that hosts the CoRiCal tool. The estimates change when the evidence changes. As stated above, the main purpose of the calculator is to help people discuss and make informed decisions about COVID-19 vaccines. You may want to discuss this information further with your vaccine provider (e.g. GP, pharmacist or nurse).
Myocarditis is inflammation of the heart muscle. Pericarditis is inflammation of the lining around the heart. They can occur separately or at the same time.
There are many possible causes of myocarditis and pericarditis. COVID-19 can cause myocarditis and/or pericarditis in some people. Myocarditis and pericarditis are also rare complications after some COVID-19 vaccines, e.g., mRNA COVID vaccines made by Moderna or Pfizer.
Myocarditis and pericarditis are more likely in young males aged 15-40 years, and after the second dose of an mRNA COVID vaccine.
Myocarditis after COVID-19 is different and often more severe than myocarditis after a vaccine. Most people with myocarditis after a vaccine make a full recovery.
The risk of myocarditis and pericarditis are much lower in children aged 5 to 11 years compared to adolescents. The risk is also lower after a booster than the initial injections. Symptoms of myocarditis or pericarditis typically appear within 1 to 5 days of vaccination.
Common symptoms of myocarditis include:
If you are concerned about myocarditis and have any of the above symptoms, you should see a health professional.
To help parents make informed decisions, we developed a child version of the CoRiCal tool. Children with weak immune systems should consider a COVID vaccine booster every 12 months, for ages 5 to 17 (ATAGI advice, 2024). A COVID vaccine booster is not recommended for any children under the age of 5 years.
This frequently asked questions (FAQ) webpage outlines some of the questions that parents have asked about the COVID-19 vaccines. This includes side effects and how likely the COVID-19 vaccine is to prevent serious illness.
The information is consistent with ATAGI and the National Centre for Immunisation Research and Surveillance (NCIRS).
Are children at risk of getting COVID-19?
Yes. Everyone is at risk of getting COVID-19. Studies show that children and adolescents can play a role in spreading the SARS-CoV-2 virus. This is the virus that causes COVID-19. Spread between young children is just as common as spread between adults. The Omicron variants of COVID-19 are easier to spread. They cause more cases in children, but do not cause more severe disease. Children are most likely to catch COVID-19 from unvaccinated adults (household or close family) and at school. Children tend to get mild disease, and most do not need to go to hospital. Rarely, around 1 in 3000 children infected with COVID-19 develop a post-COVID inflammatory syndrome that affects many organs in their body. This is called paediatric inflammatory multisystem syndrome temporarily associated with SARS-CoV-2 (PIMS-TS). It is also called multisystem inflammatory syndrome in children (MIS-C).
Which children are most at risk from getting COVID-19?
Some conditions increase the risk of children needing to go to hospital with COVID-19. This includes:
While COVID-19 is mild in most children, a few can become very sick and have long term effects. Children are more likely to become very sick from COVID-19 if they have certain conditions (see list above). The COVID-19 vaccine reduces the chance that a child will get very sick from COVID-19. There is also some evidence that the vaccine reduces the chance of children getting multi-inflammatory syndrome after they catch COVID-19. Children can spread COVID-19 to others, especially members of their family and household. Vaccinated people are less likely to pass on the virus than unvaccinated people. The 2024 ATAGI advice on COVID vaccination boosters is shown below (Table 1).
Side effects are not common, but the COVID-19 vaccine can cause local injection-site pain, redness and swelling, headaches or general aches and pains. These side effects usually go away quickly. More severe reactions are very uncommon. A very small number of children get myocarditis (inflammation of the heart muscle) after the COVID-19 vaccine. This is more likely to happen after catching COVID-19 (see above). Myocarditis after getting COVID-19 is more severe than myocarditis after a COVID-19 vaccine.
In Australia, the Pfizer COVID-19 vaccine is approved and available for children aged over 5 years. The Moderna COVID-19 vaccine is registered and available for children ≥ 12 years. This is based on 2024 ATAGI advice. See their website for the most up-to-date information.
Novavax XBB.1.5 vaccine was not available when this model was developed. The original Novavax vaccine can be given to people aged 12 years and older, but ATAGI suggests that XBB.1.5-based vaccines are preferred. See their website for more information.
The long COVID version of CoRiCal aims to help people understand their chance of feeling unwell six months after getting COVID-19 (long COVID).
What is long COVID and who does it affect?
Long COVID is also known as post-COVID-19 condition or post-acute sequelae (consequences) of COVID-19. Long COVID means feeling unwell a long time after the infection (12 weeks or more). This can include continued, returning or new symptoms, that are not due to any other diagnosis.
These symptoms can impact everyday life and make it difficult to complete tasks, exercise, or work. While many people get better over time, some still have symptoms two years later or more. For this calculator, we show the chance of having long COVID 6 months after infection. Long COVID can happen after infection with any SARS-CoV-2 strain, but this calculator focuses on the Omicron variant.
The symptoms of long COVID can overlap with other conditions.
Post-acute viral infection syndromes include the symptoms listed below. See here for more information.
Chronic fatigue syndrome includes fatigue, brain fog and post-exertional malaise. See here for more information.
The best way to prevent long COVID is to avoid getting COVID-19 in the first place. You can lower your chance of infection in several ways:
If you do get COVID-19, you can lower you chance of getting long COVID by getting antiviral drugs in your first week of infection. Ask your doctor to check if you are eligible for government funding for these drugs. Getting COVID-19 vaccines can also provide some protection against getting long COVID.
The calculator considers the antiviral drugs listed below:
For more information on data sources, please read the document in the ‘MORE INFO’ section. For more information about antiviral drugs, eligibility criteria and cost, see the below links:
Some great resources are listed below:
CoRiCal co-chairs: Colleen Lau, John Litt, Kirsty Short
Project conception: Andrew Baird, John Litt, Kirsty Short
Web Development: Aapeli Vuorinen, Tina Moghaddam, Hongen Lu
Subject expertise: Andrew Baird, Anoop Enjeti, Colleen Lau, John Litt, Raj Puranik, Kirsty Short, Tej Shukla, Sudhir Wahi, Olivia Williams, Sophie Wen, Phil Britton
Model design: Colleen Lau, Helen Mayfield, Kerrie Mengersen, Tej Shukla, Jane Sinclair, Ramona Muttucumaru, Sam Brown, Olivia Williams
Data acquisition: Andrew Baird, Anoop Enjeti, Colleen Lau, John Litt, Tej Shukla, Kirsty Short
Data analysis: Samuel Brown, Colleen Lau, Helen Mayfield, Kerrie Mengersen, Jane Sinclair, Michael Waller
Risk Communication: Carissa Bonner (videos), Colleen Lau, John Litt, Kirsty Short, Jane Sinclair
Administration and project management: Jayne Geddes, John Litt, Helen Mayfield, Kim Sampson, Kirsty Short, Hongen Lu